Changes over time in creatinine clearance and comparison of emergent adverse events for HIV-positive adults receiving standard doses (300 mg/day) of lamivudine-containing antiretroviral therapy with baseline creatinine clearance of 30-49 vs =50 mL/min. (2019)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1371/journal.pone.0225199
PubMed Identifier: 31725787
Publication URI: http://europepmc.org/abstract/MED/31725787
Type: Journal Article/Review
Volume: 14
Parent Publication: PloS one
Issue: 11
ISSN: 1932-6203